Rationale and Design of Low-dose Administration of Carperitide for Acute Heart Failure (LASCAR-AHF)
Toshiyuki Nagai(Hokkaido University), Toshihisa Anzai(Hokkaido University), Satoshi Yasuda(Tohoku University), Takeshi Aiba(National Cerebral and Cardiovascular Center), Hiroki Nakano(Honda (Japan)), Hideaki Kanzaki(National Cerebral and Cardiovascular Center), Nobuyuki Komiyama(St. Luke's International Hospital), Hisao Ogawa(Kumamoto University Hospital), Takafumi Yamane, Atsushi Mizuno(St. Luke's International Hospital), Satoshi Honda(National Cerebral and Cardiovascular Center), Yasuyuki Honda(National Cerebral and Cardiovascular Center), Nobuhiro Tanaka(Tokyo Medical University Hachioji Medical Center), Teruo Noguchi(National Cerebral and Cardiovascular Center), Yasuhide Asaumi(National Cerebral and Cardiovascular Center), Yutaka Furukawa(Kobe City Medical Center General Hospital), Toshimitsu Hamasaki(National Cerebral and Cardiovascular Center), Kengo Kusano(Northwestern University), Naotsugu Iwakami(Kyoto University), Syuzo Nishihara(Tokyo Medical University Hachioji Medical Center), Yoshio Tahara(National Cerebral and Cardiovascular Center), Yasuo Sugano(keiyu Hospital), Taichi Adachi(National Hospital Organization), Tadayoshi Miyagi(Okinawa Prefectural Chubu Hospital)
Cited by 10
Related Papers
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.
|Circulation|1994|1.3k